The independent source for health policy research, polling, and news.
Rachel Bluth was a correspondent for ºÚÁϳԹÏÍø News until February 2023.
Showing 121 - 140 of 162
The federal government plans to spend millions of dollars less this year on advertising and outreach efforts to support the health law’s open enrollment period, which starts Nov. 1.
Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.
Growing numbers of physicians say they support a single-payer health care system, a 180-degree turn in opinion over a decade.
Sen. Patty Murray questions Dr. Brett Giroir’s willingness to stand up for women’s health programs such as family planning services and teenage pregnancy prevention.
The Senate’s vote to proceed with debate on an Obamacare repeal bill had drama and plenty of color, but you couldn’t get the complete picture on TV.
A coalition of health care providers are blocking Ohio’s law requiring health care providers to tell what non-emergency services will cost them.
Where women prefer to go for health care becomes a proxy for the abortion debate.
Sen. John McCain’s surgery impacted Senate Majority Leader Mitch McConnell’s ambition to push health care bill forward this week.
Scenes from Capitol Hill Tuesday as Senate Majority Leader Mitch McConnell’s effort to pass a health care bill this week crumbled.
Experts say the loopholes would allow states to bypass some protections for people with preexisting conditions.
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Tom Price defends proposed spending reductions in Medicaid and other HHS programs while demurring on questions about cost-sharing subsidies for the 2018 Obamacare marketplace.
In the early stages of the Senate’s attempts to write a health care bill, a Republican and a Democrat each solicit constituents’ Obamacare experiences from opposite ends of the spectrum.
The Buffalo News reports the Buffalo, N.Y.-area Republican has drawn inquiries from the Office of Congressional Ethics related to his investment in Australian biotech company Innate Immunotherapeutics.
The two Republican lawmakers sent a letter to HHS Secretary Tom Price warning him that whistleblowers in HHS could be intimidated into silence by a department memo instructing employees to get clearance before talking with members of Congress and their staffs.
Rep. Jim Jordan, R-Ohio, sparked discord at his meeting with his district's voters Monday when he suggested churches, schools and families are best able to handle the opioid epidemic rather than the federal government.
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
Sen. Bernie Sanders’ bill to allow Americans to buy cheaper medicines from Canada would bypass a requirement that blocked past legislative efforts over two decades.
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF